Prognostic Implication of KRAS Status after Hepatectomy for Colorectal Liver Metastases Varies According to Primary Colorectal Tumor Location.

about

Association of BRAF Mutations With Survival and Recurrence in Surgically Treated Patients With Metastatic Colorectal Liver Cancer

P2860

Q56969146-818F6AA6-E71C-4F2F-A539-07365214951E

P2860

Prognostic Implication of KRAS Status after Hepatectomy for Colorectal Liver Metastases Varies According to Primary Colorectal Tumor Location.

Item

http://www.wikidata.org/entity/Q38847613

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Prognostic Implication of KRAS ...... ary Colorectal Tumor Location.

@en

type

Item

label

Prognostic Implication of KRAS ...... ary Colorectal Tumor Location.

@en

prefLabel

Prognostic Implication of KRAS ...... ary Colorectal Tumor Location.

@en

P1476

Prognostic Implication of KRAS ...... mary Colorectal Tumor Location

@en

P2093

Ana Wilson

http://www.w3.org/2001/XMLSchema#string

Faiz Gani

http://www.w3.org/2001/XMLSchema#string

Georgios A Margonis

http://www.w3.org/2001/XMLSchema#string

Kazunari Sasaki

http://www.w3.org/2001/XMLSchema#string

Neda Amini

http://www.w3.org/2001/XMLSchema#string

Nikolaos Andreatos

http://www.w3.org/2001/XMLSchema#string

Yuhree Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

Different treatment strategies and molecular features between right-sided and left-sided colon cancers

Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer

Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer

Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation status

Relevance of Ki-67 antigen expression and K-ras mutation in colorectal liver metastases.

Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases.

Left-sided primary tumors are associated with favorable prognosis in patients with KRAS codon 12/13 wild-type metastatic colorectal cancer treated with cetuximab plus chemotherapy: an analysis of the AIO KRK-0104 trial.

Context-dependent interpretation of the prognostic value of BRAF and KRAS mutations in colorectal cancer.

Characterisation of colorectal cancers showing hypermethylation at multiple CpG islands.

P2888

s10434-016-5361-6

P304

3736-3743

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1245/S10434-016-5361-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Stefan Buettner

Gaya Spolverato

Timothy Pawlik

P577

2016-06-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1030174514

http://www.w3.org/2001/XMLSchema#string

P698

27352204

http://www.w3.org/2001/XMLSchema#string

P921

hepatectomy

Prognostic Implication of KRAS Status after Hepatectomy for Colorectal Liver Metastases Varies According to Primary Colorectal Tumor Location.

about

P2860

P2860

Prognostic Implication of KRAS Status after Hepatectomy for Colorectal Liver Metastases Varies According to Primary Colorectal Tumor Location.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921